Search Results - "Benassi, Virginia"

Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development by Bopp, Nathen E., Kaiser, Jaclyn A., Strother, Ashley E., Barrett, Alan D. T., Beasley, David W. C., Benassi, Virginia, Milligan, Gregg N., Preziosi, Marie-Pierre, Reece, Lisa M.

“…Severe fever with thrombocytopenia syndrome virus (SFTSV) is a newly emergent tick-borne bunyavirus first discovered in 2009 in China. SFTSV is a growing…”
Get full text

Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses by Pan, Hongchao, Peto, Richard, Henao Restrepo, Ana Maria, Preziosi, Marie-Pierre, Sathiyamoorthy, Vasee, Karim, Quarraisha Abdool, Alejandria, Marissa, Hernàndez García, César, Kieny, Marie-Paule, Malekzadeh, Reza, Murthy, Srinivas, Reddy, K. Srinath, Periago, Mirta Roses, Hanna, Pierre Abi, Abutidze, Akaki, Ader, Florence, Al-Bader, Abdullah, Alhasawi, Almonther, Allum, Emma, Al Mawali, Adhra, Alotaibi, Athari, Alvarez- Moreno, Carlos, Appadoo, Sheila, Arts, Derk, Asiri, Abdullah, Aukrust, Pål, Barratt-Due, Andreas, Genetu Bayih, Abebe, Beaumont, Helena, Bellani, Samir, Benassi, Virginia, Bhargava, Balram, Branca, Mattia, Cappel-Porter, Heike, Cerrato, Nery, Cheick Haidara, Fadima, Chow, Ting Soo, Como, Nadia, Eustace, Joe, Gabunia, Tamar, García, Patricia, Godbole, Sheela, Gotuzzo, Eduardo, Griskevicius, Laimonas, Hamra, Rasha, Hassan, Mariam, Hassany, Mohamed, Hutton, David, Irmansyah, Irmansyah, Jancoriene, Ligita, Khamis, Faryal, Kirwan, Jana, Kumar, Suresh, Lennon, Peter, Lopardo, Gustavo, Lydon, Patrick, Magrini, Nicola, Manevska, Suzana, Manuel, Oriol, McGinty, Sybil, Medina, Marco, Mesa Rubio, Maria Lucia, Miranda Montoya, Maria Consuelo, Nel, Jeremy, Nunes, Estevao, Perola, Markus, Portoles, Antonio, Rasmin, Menaldi, Raza, Aun, Rees, Helen, Reges, Paula, Rogers, Chris, Salami, Kolawole, Salvadori, Marina, Sauermann, Mamatha, Sinani, Narvina, Sow, Samba, Sterne, Jonathan AC, Stevanovikj, Milena, Tacconelli, Evelina, Tavares Maltez, Fernando Manuel, Teferi, Mekonnen, Tikkinen, Kari, Trelle, Sven, Tsertsvadze, Tengiz, Zaid, Hala, Røttingen, John-Arne, Swaminathan, Soumya, Ryan, Michael, Gjermeni, Nevila, Meta, Esmeralda, Aguila, Damian, Alonso, Ignacio, Altamirano, Marcos, Alvarez, María, Alzola, Rodrigo, Arce, Veronica, Arribillaga, Patricia, Avila, Rafael, Balbuena, Juan

“…The Solidarity trial among COVID-19 inpatients has previously reported interim mortality analyses for four repurposed antiviral drugs. Lopinavir,…”
Get full text

Research and product development for Crimean–Congo haemorrhagic fever: priorities for 2024–30 by Semper, Amanda E, Olver, Janie, Warner, Jenny, Cehovin, Ana, Fay, Petra C, Hart, Peter J, Golding, Josephine P, Benassi, Virginia, Preziosi, Marie-Pierre, Al-Asadi, Khdair Hazbar Razzaq, Blumberg, Lucille H, de la Fuente, José, Elaldi, Nazif, Fletcher, Tom, Formenty, Pierre B H, Gouya, Mohammad Mehdi, Günther, Stephan, Hewson, Roger, Jamil, Bushra, Kobinger, Gary, Korukluoglu, Gülay, Lempereur, Laetitia, Palacios, Gustavo, Papa, Anna, Pshenichnaya, Natalia, Schmaljohn, Connie, Sow, Samba O, Sprong, Hein, Vatansever, Zati, Brooks, Timothy J G

“…Crimean–Congo haemorrhagic fever (CCHF) is a widely distributed and potentially fatal tick-borne viral disease with no licensed specific treatments or…”
Get full text

Measures to prevent and treat Nipah virus disease: research priorities for 2024–29 by Moore, Kristine A, Mehr, Angela J, Ostrowsky, Julia T, Ulrich, Angela K, Moua, Nicolina M, Fay, Petra C, Hart, Peter J, Golding, Josephine P, Benassi, Virginia, Preziosi, Marie-Pierre, Broder, Christopher C, de Wit, Emmie, Formenty, Pierre B H, Freiberg, Alexander N, Gurley, Emily S, Halpin, Kim, Luby, Stephen P, Mazzola, Laura T, Montgomery, Joel M, Spiropoulou, Christina F, Mourya, Devendra T, Parveen, Shahana, Rahman, Mahmudur, Roth, Cathy, Wang, Lin-Fa, Osterholm, Michael T

“…Nipah virus causes highly lethal disease, with case-fatality rates ranging from 40% to 100% in recognised outbreaks. No treatments or licensed vaccines are…”
Get full text

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade by Moore, Kristine A, Ostrowsky, Julia T, Mehr, Angela J, Johnson, Rebecca A, Ulrich, Angela K, Moua, Nicolina M, Fay, Petra C, Hart, Peter J, Golding, Josephine P, Benassi, Virginia, Preziosi, Marie-Pierre, Adetifa, Ifedayo M, Akpede, George O, Ampofo, William K, Asogun, Danny A, Barrett, Alan D T, Bausch, Daniel G, de Coster, Ilse, Emperador, Devy M, Feldmann, Heinz, Fichet-Calvet, Elisabeth, Formenty, Pierre B H, Garry, Robert F, Grant, Donald S, Günther, Stephan, Gupta, Swati B, Jaspard, Marie, Mazzola, Laura T, Okogbenin, Sylvanus A, Roth, Cathy, Schmaljohn, Connie S, Osterholm, Michael T

“…In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of…”
Get full text